Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)
China flag China · Delayed Price · Currency is CNY
41.90
-0.03 (-0.07%)
Apr 30, 2025, 3:00 PM CST

SHA:600976 Revenue

Jianmin Pharmaceutical Group had revenue of 892.08M CNY in the quarter ending March 31, 2025, a decrease of -8.04%. This brings the company's revenue in the last twelve months to 3.43B, down -17.82% year-over-year. In the year 2024, Jianmin Pharmaceutical Group had annual revenue of 3.50B, down -16.81%.

Revenue (ttm)
3.43B
Revenue Growth
-17.82%
P/S Ratio
1.88
Revenue / Employee
1.37M
Employees
2,497
Market Cap
6.43B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20243.50B-708.17M-16.81%
Dec 31, 20234.21B572.35M15.72%
Dec 31, 20223.64B341.37M10.35%
Dec 31, 20213.30B843.43M34.34%
Jan 1, 20212.46B217.06M9.69%
Jan 1, 2020 Pro Pro Pro
Jan 1, 2019 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition